Insiders · Profile

Schoenherr Thomas Edward

CEO, Diagnostics at Tempus AI. Filing since 19 May 2026. CIK 0002113721

Company
Date
Role
Action
Shares
Amount
Of holding
25 Sep 2026
CEO, Diagnostics
Sold on a plan
10,281
$873.89K
11.8%
21 Aug 2026
CEO, Diagnostics
Bought on a plan
2,694
$188.58K
3.2%
19 Aug 2026
CEO, Diagnostics
Sold on a plan
8,082
$471.99K
8.3%
18 Aug 2026
CEO, Diagnostics
Sold on a plan
9,232
$458.00K
8.6%
19 May 2026
CEO, Diagnostics
Sold at will
1,580
$69.63K
1.5%
5 decisions on file.